Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Nanopore Technologies Regulatory News (ONT)

Share Price Information for Oxford Nanopore Technologies (ONT)

Share Price is delayed by 15 minutes
Get Live Data
118.90    4.50 (3.93%)
Bid:
119.20
Ask:
119.90
Spread: 0.70 (0.587%)
Market Cap: £1.16b
ONT Live PriceLast checked at - London Stock Exchange

Intraday Oxford Nanopore Technologies Share Chart

Director/PDMR Shareholding

12 Apr 2022 13:01

RNS Number : 1494I
Oxford Nanopore Technologies plc
12 April 2022
 

12 April 2022

Oxford Nanopore Technologies plc (the "Company")

Director/PDMR Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company announces that on 11 April 2022, it made conditional awards over ordinary shares of £0.0001 each under the Oxford Nanopore Technologies plc Deferred Bonus Plan 2021 ("DBP"), to those Persons Discharging Managerial Responsibilities (each a "PDMR") outlined below.

Name of PDMR

Number of shares subject to award granted under DBP

Gordon Sanghera (Director)

72,226

Clive Brown (Director)

44,795

Timothy Cowper (Director)

33,486

Spike Willcocks (Director)

48,441

 

The DBP awards relate to the deferral into shares of 33.3% of the bonuses paid to the PDMRs in relation to the financial year ending 31 December 2021. Under the Company's directors' remuneration policy, at least 33.3% of the annual bonus payable to the directors is settled in DBP awards, with 50% of the relevant DBP award vesting on the first anniversary of the award date and the remaining 50% vesting on the second anniversary of the award date. The shares will accrue a dividend equivalent between the award date and the relevant vesting date.

The number of shares over which the DBP awards were granted was calculated based on a price of £3.82 per share. This is the average closing middle-market share price, as derived from the Daily Official List of the London Stock Exchange, for the five business days preceding the award date.

This announcement is made pursuant to the Company's obligations under Article 19 of the UK Market Abuse Regulation.

Gordon Sanghera - DBP award granted

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Gurdial (Gordon) Sanghera

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Award granted under the Deferred Bonus Plan 2021

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

72,226

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

72,226

£Nil

e)

Date of the transaction

11 April 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

Clive Brown - DBP award granted

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Clive Brown

2

Reason for the notification

a)

Position/status

Chief Technology Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Award granted under the Deferred Bonus Plan 2021

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£Nil

44,795

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

44,795

£Nil

e)

Date of the transaction

11 April 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

Timothy Cowper - DBP award granted

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Timothy Cowper

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Award granted under the Deferred Bonus Plan 2021

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£Nil

33,486

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

33,486

£Nil

e)

Date of the transaction

11 April 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

Spike Willcocks - DBP award granted

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James (Spike) Willcocks

2

Reason for the notification

a)

Position/status

Chief Strategy Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Award granted under the Deferred Bonus Plan 2021

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£Nil

48,441

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

48,441

Nil

e)

Date of the transaction

11 April 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

[ENDS]

Enquiries:

Investors

ir@nanoporetech.com 

Media 

media@nanoporetech.com

oxfordnanoporetechnologies@tulchangroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBGDSGUBDGDD
Date   Source Headline
21st Jul 20257:00 amRNSHalf Year Trading Update and Notice of Results
14th Jul 20256:00 pmRNSShare Incentive Plan - Director/PDMR Notification
4th Jul 20254:30 pmRNS-RPublication of 2024 Sustainability Report
1st Jul 20255:00 pmRNSIssue of Equity and Total Voting Rights
27th Jun 20258:30 amRNSHolding(s) in Company
18th Jun 20259:30 amRNSHolding(s) in Company
12th Jun 20254:00 pmRNSShare Incentive Plan - Director/PDMR Notification
11th Jun 20255:30 pmRNSHolding(s) in Company
5th Jun 20255:55 pmRNSChanges in Composition of Remuneration Committee
4th Jun 20251:00 pmRNSResult of AGM
3rd Jun 20257:00 amRNSIssue of Equity and Total Voting Rights
2nd Jun 20258:00 amRNSHolding(s) in Company
22nd May 20257:00 amRNS-RLondon Calling Technology Update
14th May 20253:00 pmRNSShare Incentive Plan - Director/PDMR Notification
1st May 20254:30 pmRNSIssue of Equity and Total Voting Rights
30th Apr 20256:15 pmRNSFounder LTIP - Director/PDMR Notification
30th Apr 20257:00 amRNSPublication of Annual Report and Notice of AGM
24th Apr 202512:00 pmRNSHolding(s) in Company
10th Apr 20252:00 pmRNSHolding(s) in Company
9th Apr 20252:00 pmRNSBlock listing Interim Review
9th Apr 202512:00 pmRNSOxford Nanopore and Cepheid collaboration
2nd Apr 20259:30 amRNSIssue of Equity and Total Voting Rights
26th Mar 20252:30 pmRNSDirector/PDMR Shareholding
14th Mar 20253:00 pmRNSSIP PDMR Notification - Correction
13th Mar 20253:00 pmRNSShare Incentive Plan - Director/PDMR Notification
12th Mar 20255:00 pmRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSHolding(s) in Company
5th Mar 20255:34 pmRNSHolding(s) in Company
4th Mar 20257:00 amRNSAnnual results for the year ended 31 December 2024
3rd Mar 20255:00 pmRNSIssue of Equity and Total Voting Rights
19th Feb 20257:00 amRNSHolding(s) in Company
7th Feb 20253:00 pmRNSShare Incentive Plan - Director/PDMR Notification
4th Feb 202512:00 pmRNSHolding(s) in Company
3rd Feb 20255:30 pmRNSIssue of Equity and Total Voting Rights
13th Jan 20253:00 pmRNSSIP PDMR Notification and Correction
13th Jan 20257:00 amRNSFull Year Trading Update and Notice of Results
6th Jan 20255:00 pmRNSHolding(s) in Company
2nd Jan 20254:00 pmRNSIssue of Equity and Total Voting Rights
16th Dec 20244:30 pmRNSDirectorate Change - Appointment of SID
11th Dec 20243:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
9th Dec 202412:00 pmRNSHolding(s) in Company
2nd Dec 20245:45 pmRNSIssue of Equity and Total Voting Rights
28th Nov 20247:00 amRNSClass A LAT share - Director/PDMR Notification
27th Nov 20247:00 amRNSOxford Nanopore and UK Biobank collaboration
26th Nov 20247:00 amRNSProposed cancellation of LAT shares
21st Nov 20241:00 pmRNSHolding(s) in Company
12th Nov 20244:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
11th Nov 20247:00 amRNSChanges to the senior leadership team
6th Nov 20247:00 amRNSApproval of the transfer of listing category
4th Nov 20249:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.